New Norwegian biotech law will ban PID (pre-implantation diagnostics):
This article was originally published in Clinica
Executive Summary
The Norwegian government is putting forward proposals for a new biotechnology law that will, among other things, ban pre-implantation diagnostics because it entails "the differentiation of eggs according to specific genetic characteristics". The new law will uphold existing bans on therapeutic cloning and research carried out on fertilised eggs. It will also continue to restrict access to genetic information outside the health service, but will ensure that inherited family diseases are properly documented. In addition, there will be a ban on paternity tests during the embryonic stage, except in rape cases.